(51 days)
No
The device description and intended use focus on a mechanical constriction device and do not mention any computational or data-driven components.
Yes
The device is intended to treat erectile dysfunction and conditions that lead to it, such as venous leakage, diabetes, and psychogenic impotence, by maintaining penile rigidity. It also treats premature ejaculation.
No
The device is a penile constriction device used to maintain penile rigidity for men with erectile dysfunction. It is a treatment device, not a diagnostic one.
No
The device description clearly details physical components made of elastic and soft rubber-like material, a cuff, a quick release loop, and a mounting tube made of acrylic. These are all hardware components, not software.
Based on the provided information, the Erco-Ribbon ™ - C is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD Definition: In vitro diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening.
- Erco-Ribbon ™ - C Function: The Erco-Ribbon ™ - C is a physical device applied externally to the penis to maintain rigidity by restricting blood outflow. It does not analyze any biological samples.
- Intended Use: The intended use clearly states it's for maintaining penile rigidity in men with erectile dysfunction, either separately or as part of a vacuum constriction system. This is a mechanical function, not a diagnostic one.
Therefore, the Erco-Ribbon ™ - C falls under the category of a medical device, but not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Erco-Ribbon ™-C is used to maintain penile rigidity in men with erectile dysfunction . It restricts blood outflow from the penis after the patient has obtained an erection (either with the aid of a vacuum pump or naturally). Men with firm but short lasting erection may use constricting device separately. If a man is impotent to a degree that he is unable to achive a natural erection, a vacuum constriction system may help him to overcome this dysfinction.
Erco-Ribbon ™-C can be used for patients with following conditions: a) separately: premature ejaculation firm but short lasting erection
b) as a part of a vacuum constriction system Diabetes Venous leakage Prostatectomy Hypertension Psychogenic condition Impotence due to radiation therapy Spinal cord injury
Product codes
78 LKY
Device Description
Erco-Ribbon ™-C is an improved version of Erco-Ribbon ™, using a cuff for forming a shell around the ribbon and a quick release loop for removing the constrictor. A constriction ribbon is made of elastic and soft rubber-like material with generally rectangular cross section.
For arrangement of Erco-Ribbon ™-C penile constriction device, the ribbon is wrapped with the tension by multyple turns over the proximal end of the mounting tube (or a vacuum chamber, when Erco-Ribbon ™-C is used as a part of a vacuum constriction system). Erco-Ribbon ™-C is locked by the cuff in a state with prearranged inward pressure. A quick release loop unlocks the constrictor and allows easy removal of the ribbon. The materials conform FDA regulation for devices contacting human skin. A mounting tube is made of a segment of acrylic tube.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
penis
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K841257, K891125, K901223, K902240, K960828
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5020 External penile rigidity devices.
(a)
Identification. External penile rigidity devices are devices intended to create or maintain sufficient penile rigidity for sexual intercourse. External penile rigidity devices include vacuum pumps, constriction rings, and penile splints which are mechanical, powered, or pneumatic devices.(b)
Classification. Class II (special controls). The devices are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9. The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: External Penile Rigidity Devices.” See § 876.1(e) for the availability of this guidance document.
0
ersum22d8
ERCONS, Inc
66 Overlook Terrace, s-te 2E New York, NY 10040 Tel. 1-212-927 3275 Fax 1-212-927 7387
510(k) SUMMARY
for
ERCO-RIBBON ™-- C
Constriction Device for Penile Rigidity
Submitter: Dr. Yakov Altshuler, Vice President
Date: Dec. 22, 1998
Trade name - Erco-Ribbon ™-C
Common name - constriction device for external penile rigidity system
Equivalence is claimed to:
| ErecAid | Osbon Medical Systems, Ltd. | K841257 |
|---|---|---|
| Confidence | Performance, Inc. | K891125 |
| VED | Mission Pharmacal Co. | K901223 |
| VET | VET-CO, Inc. | K902240 |
| Pos-T-Vac | POS-T-VAC | K960828 |
| Erco-Ribbon TM | Ercons, Inc. | K981343 |
| Code of Federal Regulation (CFR) Number: | Unclassified | |
| Product Code: | 78 LKY |
PATENT PENDING Erco-Ribbon ™-C CONFIDENTIAL Dec.1998
1
Intended Use
Erco-Ribbon ™-C is used to maintain penile rigidity in men with erectile dysfunction . It restricts blood outflow from the penis after the patient has obtained an erection (either with the aid of a vacuum pump or naturally). Men with firm but short lasting erection may use constricting device separately. If a man is impotent to a degree that he is unable to achive a natural erection, a vacuum constriction system may help him to overcome this dysfinction.
Erco-Ribbon ™-C can be used for patients with following conditions: a) separately: premature ejaculation firm but short lasting erection
b) as a part of a vacuum constriction system Diabetes Venous leakage Prostatectomy Hypertension Psychogenic condition Impotence due to radiation therapy Spinal cord injury
PATENT PENDING Erco-Ribbon ™-C CONFIDENTIAL Dec.1998
2
DESCRIPTION
Erco-Ribbon ™-C is an improved version of Erco-Ribbon ™, using a cuff for forming a shell around the ribbon and a quick release loop for removing the constrictor. A constriction ribbon is made of elastic and soft rubber-like material with generally rectangular cross section.
For arrangement of Erco-Ribbon ™-C penile constriction device, the ribbon is wrapped with the tension by multyple turns over the proximal end of the mounting tube (or a vacuum chamber, when Erco-Ribbon ™-C is used as a part of a vacuum constriction system). Erco-Ribbon ™-C is locked by the cuff in a state with prearranged inward pressure. A quick release loop unlocks the constrictor and allows easy removal of the ribbon. The materials conform FDA regulation for devices contacting human skin. A mounting tube is made of a segment of acrylic tube.
SUBSTANTIAL EQUIVALENCY COMPARISON
Comparison of design and performance of marketable constriction rings and Erco-Ribbon ™-C is made with consideration of the impact of device's design on its safety and effectiveness.
Considered marketable Predicate devices and Erco-Ribbon ™-C are constriction devices with the same intended use, but have different technological characteristics.
PATENT PENDING Erco-Ribbon ™-C CONFIDENTIAL Dec.1998
3
3
Predicate devices:
To provide sufficient inward pressure on erected penis, one or more of constriction rings have to be placed at the edge of an open end of the vacuum chamber.
Rings are molded of natural or synthetic rubber with different durometer numbers, usually in the range of 30 to 60 and are manufactured in large, medium and small sizes. To provide acceptable inward pressure, selection for individual users is based on size, durometer and a number of constriction rings used together. Despite high cost due to a number of expensive molds, there is no way to provide smooth control of the pressure which happens to be excessive and causes discomfort, numbness, bruises. Placement of rings presents certain technical difficulties. Recognizing this problem, special cone-shaped applicators are added to the system. Applicators facilitate the problem, but complicate the system and increase its cost.
Discomfort and pain may be caused by twisting of doubled rings during their transfer onto the penis and because of intertwining with pubic hair. Removal of constriction ring from erected penis could be painful too, especially when two or more rings are used together. In this case after removal of the first ring the penis is still engorged, as the remaining ring prevents blood outflow.
PATENT PENDING Erco-Ribbon ™-C CONFIDENTIAL Apr,1998
4
4
Erco-Ribbon ™-C:
With the constrictor of given properties and dimensions, the user may prearrange desirable pressure by changing the tension and number of turns during wrapping. The present design radically reduces major technical difficulties of constriction ring associated with its placement on the vacuum chamber. A multyturn constriction ribbon is much easier to apply than a solid constriction ring as the force necessary to extend multyturn constrictor is much lower than for solid ring.
SUMMARY:
Erco-Ribbon ™-C has the same intended use as Predicate devices. Technological differences of Erco-Ribbon ™-C provide superior safety and performance.
Erco-Ribbon ™-C is substantially equivalent to constriction devices that have been marketed for many years.
PATENT PENDING Erco-Ribbon ™-C CONFIDENTIAL Dec.1998
5
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 2 4 1999
Yakov Altshuler, Ph.D. Vice President ERCONS, Inc. 66 Overlook Terrace, Suite 2E New York, NY 10040
Re: K990008 Erco-Ribbon™ -C, Accessory to Vacuum Erection Device Dated: December 23, 1998 Received: January 4, 1999 Unclassified/Procode: 78 LKY
Dear Dr. Altshuler:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act, You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
signature
Capt. Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
510(k) Number
Page 1 of 1
Device Name: Erco-Ribbon ™ -C
Indications for use:
Erco-Ribbon ™ - C is used to maintain penile rigidity in men with erectile dysfunction. It restricts blood outflow from the penis after the patient has obtained an erection (either with the aid of a vacuum pump, or naturally). Men with firm but short lasting erection may use constricting device separately. If a man is impotent to a degree that he is unable to achieve a natural erection, a vacuum constriction system may help him to overcome this dysfunction.
Erco-Ribbon ™ - C can be used for patients with following conditions:
- a) separately:
premature ejaculation,
firm but short lasting erection.
b) as a part of a vacuum constriction system:
Diabetes
Venous leakage
Prostatectomy
Hypertension
Psychogenic impotence
Impotence due to radiation therapy
Spinal cord injury
1
Concurrence of CDRH, Office of Device Evaluation Evaluation (ODE)
Prescription Use __ OR Over-The-Counter Use
(Per 21 CFR 8 __) (Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
4990008
and Radiological Devic
510(k) Number_